| Anesthesiology
Blood salvage
Blood substitutes
Cardiac surgery
Coagulants
Pharmacological strategies to decrease excessive
blood loss in cardiac surgery: a meta-analysis of clinically relevant
endpoints.
Lancet.
1999 Dec 4;354(9194):1940-7.
Recombinant Factor VIIa Is Effective for Bleeding
and Surgery in Patients With Glanzmann Thrombasthenia.
Blood.
1999 Dec 1;94(11):3951-3953.
Treatment of traumatic bleeding with recombinant
factor
VIIa.
Lancet
1999 Nov 27;354(9193):1879
Reducing perioperative blood loss in patients undergoing
total
hip arthroplasty.
Int
J Artif Organs. 1999 Jan;22(1):47-51.
Aprotinin efficacy on intraoperative bleeding and transfusion
requirements in orthotopic liver transplantation.
Transfusion.
1994 Jun;34(6):507-11.
Aprotinin therapy to reduce blood loss in Jehovah's
Witnesses.
Can
J Anaesth. 1994 Jan;41(1):77-8. No abstract available.
Recombinant factor VIIa for intracranial haemorrhage
in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.
Blood
Coagul Fibrinolysis. 1993 Dec;4(6):1031-3.
Erythropoietin
Cost-effectiveness of epoetin and autologous blood
donation in reducing allogeneic blood transfusions in coronary artery bypass
graft surgery
Transfusion
2000 40: 673-681
Recombinant human erythropoietin improves health-related
quality of life in patients with rheumatoid arthritis and anaemia
of chronic disease; utility measures correlate strongly with disease
activity measures.
Rheumatol
Int. 1999;18(5-6):201-6.
Optimizing erythropoietin therapy.
Curr
Opin Hematol. 1999 May;6(3):121-6.
Recombinant human erythropoietin treatment of postpartum
anemia. Preliminary results.
Eur
J Obstet Gynecol Reprod Biol. 1998 Oct;81(1):27-31.
Erythropoietin therapy.
N
Engl J Med. 1997 Mar 27;336(13):933-8. Review. No abstract available
Erythropoietin permits high-dose chemotherapy with peripheral
blood stem-cell transplant for a Jehovah's Witness.
Am
J Hematol. 1997 May;55(1):51-2. No abstract available.
Recombinant erythropoietin for the treatment of anemia
in inflammatory bowel disease.
N
Engl J Med 1996 Mar 7;334(10):619-23
Erythropoetin accelerates hematocrit recovery in post-surgical
anemia.
Am
Surg. 1995 Jan;61(1):74-7.
General surgery
Major hepatic resection without blood transfusion:
experience with total vascular exclusion
J
Gastroenterol Hepatol 1999 May;14 Suppl:S28-31
Extended hemipelvectomy in a Jehovah's Witness
with erythropoietin support.
Am
Surg. 1998 Nov;64(11):1074-6.
Elective splenectomy in an anemic Jehovah's Witness
patient with cirrhosis.
Anesth
Analg. 1998 Sep;87(3):529-30. No abstract available.
Pancreaticoduodenectomy without homologous blood
transfusion in an anemic Jehovah's Witness.
Arch
Surg. 1992 Mar;127(3):349-51.
Elective surgery without transfusion: influence
of preoperative hemoglobin level and blood loss on mortality.
Am
J Surg. 1990 Mar;159(3):320-4.
Gynecologic surgery
Uterine Artery Embolization for Fibroids: Considerations
in Patient Selection and Clinical Follow-up
Medscape
Women's Health 4(5), 1999
Pelvic arterial embolization for control of obstetric
hemorrhage: A five-year experience.
Am
J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1454-1460.
Bloodless surgery: Establishment of a program
for the special medical needs of the Jehovah's Witness community-The gynecologic
surgery experience at a community hospital
Am
J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1491-1498
Pregnancy in a Jehovah's witness with cervical cancer
and anemia.
Gynecol
Oncol. 1998 Nov;71(2):330-2.
Head and neck surgery
Management of Jehovah's Witness patients undergoing major
head and neck surgery.
Head
Neck. 1999 Jan;21(1):80-4.
Head and neck surgery in the Jehovah's Witness patient.
Otolaryngol
Head Neck Surg. 1996 Apr;114(4):669-72. No abstract available.
Craniomaxillofacial surgery in the Jehovah's Witness
patient.
Plast
Reconstr Surg. 1994 May;93(6):1258-63.
Hematological diseases
Hematopoietic stem cell allografts using a
non-myeloablative conditioning regimen can be safely performed on an
outpatient basis: report of four cases.
Bone
Marrow Transplant. 2000 Jan;25(2):131-3.
Successful treatment for acute lymphoblastic leukemia
without blood transfusion in a Jehovah's Witness.
Am
J Hematol. 1999 Feb;60(2):168-9. No abstract available.
Acute leukaemia in Jehovah's Witnesses.
Br
J Haematol. 1998 Mar;100(4):664-8.
Successful treatment of acute promyelocytic leukemia
using all-trans retinoic acid and erythropoietin in a Jehovah's Witness
boy.
Ann
Hematol. 1998 Jan;76(1):43-4.
Clinical and ethical issues in the treatment of a Jehovah's
Witness with acute myeloblastic leukemia.
Arch
Intern Med. 1997 Aug 11-25;157(15):1753-7. Review.
Successful treatment of a Jehovah's Witness with acute
promyelocytic
leukemia.
Int
J Hematol. 1997 Jun;65(4):415-6. No abstract available.
Successful treatment of acute promyelocytic leukemia
in
a pregnant Jehovah's Witness with all-trans retinoic acid, rhG-CSF,
and erythropoietin.
Am
J Hematol. 1996 Mar;51(3):251-2. No abstract available.
Use of 2-chlorodeoxyadenosine, granulocyte-colony-stimulating
factor, and erythropoietin in a Jehovah's Witness with hairy cell leukemia.
Am
J Hematol. 1995 Jul;49(3):255-6. No abstract available
When to transfuse blood in sickle cell disease?
Lessons from Jehovah's Witnesses.
Ann
Clin Lab Sci. 1994 Sep-Oct;24(5):396-400.
Long-term continuous complete remission of acute myeloid
leukemia in a Jehovah's witness treated without blood support.
Haematologica.
1994 Mar-Apr;79(2):180-1.
Hypervolemic hemodilution
Hypothermia
Acute severe hemodilution to a hemoglobin of 1.3 g/dl
tolerated in the presence of mild hypothermia.
Anesthesiology
1999 Jun;90(6):1798-9
Hypotensive anesthesia
Hyperbaric oxygen therapy
Interventional radiology
Uterine Artery Embolization for Fibroids: Considerations
in Patient Selection and Clinical Follow-up
Medscape
Women's Health 4(5), 1999
Secondary Postpartum Hemorrhage: Treatment with
Selective Arterial Embolization
Radiology.
1999;212:385-389.
Pelvic arterial embolization for control of obstetric
hemorrhage: A five-year experience.
Am
J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1454-1460.
Acute hemorrhage in chronic pancreatitis: diagnosis
and treatment options including superselective microcoil embolization.
Pancreas.
1999 May;18(4):399-402.
Uterine artery embolization--a successful treatment to
control bleeding cervical pregnancy with a simultaneous intrauterine
gestation.
Hum
Reprod. 1999 Feb;14(2):553-5.
Life-threatening primary postpartum hemorrhage:
treatment with emergency selective arterial embolization.
Radiology.
1998 Aug;208(2):359-62
Selective arterial embolization for the control of lower
gastrointestinal bleeding.
Am
J Surg. 1997 Jul;174(1):24-8.
Laparoscopic surgery
Laparoscopic vs Open Splenectomy
Arch
Surg. 1999;134:1263-1269
Laparoscopic splenectomy in a Jehovah's Witness
with profound anemia.
Surg
Endosc. 1997 Aug;11(8):850-1.
Autotransfusion with laparoscopically salvaged blood
in trauma: report on 21 cases.
Surg
Laparosc Endosc. 1996 Feb;6(1):46-8.
Neurosurgery
Evaluation of acute normovolemic hemodilution for surgical
repair of craniosynostosis.
J
Neurosurg Anesthesiol. 2000 Jan;12(1):33-6.
Erythropoietin-augmented isovolemic hemodilution in skull-base
surgery. Case report.
J
Neurosurg. 1994 Apr;80(4):740-4.
Use of recombinant human erythropoietin to avoid blood
transfusion in a Jehovah's Witness requiring hemispherectomy.
Case report.
J
Neurosurg. 1993 Oct;79(4):600-2.
Normovolemic hemodilution
Evaluation of acute normovolemic hemodilution for surgical
repair of craniosynostosis.
J
Neurosurg Anesthesiol. 2000 Jan;12(1):33-6.
Hemodilution as a method to reduce transfusion requirements
in adolescent spine fusion surgery.
Spine.
1999 Feb 1;24(3):219-22; discussion 223-4.
Acute normovolemic hemodilution.
Clin
Orthop. 1998 Dec;(357):74-81. Review.
Acute normovolemic hemodilution should replace the preoperative
donation of autologous blood as
a method of autologous-blood procurement.
Transfusion.
1998 May;38(5):473-6. Review. No abstract available.
Oncology
Recombinant human erythropoietin in the treatment of cancer-related
or chemotherapy-induced anaemia in patients with solid tumours.
Med
Oncol. 1998 Aug;15 Suppl 1:S19-28. Review.
Management of chemotherapy-induced anemia in solid
tumors.
Semin
Oncol. 1998 Jun;25(3 Suppl 7):23-6. Review.
The effect of GM-CSF on reticulocytes, haemoglobin and
haematocrit in patients receiving chemotherapy for solid tumours.
Clin
Lab Haematol. 1996 Mar;18(1):7-12.
Orthopedic surgery
A comparative study of the postoperative allogeneic blood-sparing
effect of tranexamic acid versus acute normovolemic hemodilution
after total knee replacement.
Anesth
Analg. 1999 Dec;89(6):1382-7
Technologies to minimize blood transfusion in
cardiac and orthopedic surgery. Results of a practice variation survey
in nine countries. International Study of Peri-operative Transfusion (ISPOT)
Investigators.
Int
J Technol Assess Health Care. 1999 Fall;15(4):717-28
The use of fibrin tissue adhesive to reduce blood
loss and the need for blood transfusion after total knee arthroplasty.
A prospective, randomized, multicenter study
J
Bone Joint Surg Am 1999 Nov;81(11):1580-8
The use of erythropoietin in the management of Jehovah's
Witnesses who have revision total hip arthroplasty.
J
Bone Joint Surg Am. 1996 Oct;78(10):1548-52.
Management of Jehovah's Witness patients for scoliosis
surgery: the use of platelet and plasmapheresis.
J
Clin Anesth. 1997 Sep;9(6):510-3.
Conference Summaries from American Academy of Orthopaedic
Surgeons 66th Annual Meeting
February 4-8, 1999. Multicomponent Pheresis and Autologous
Platelet Gel in Children and Adolescents Undergoing Spinal Surgery
©
Medscape, Inc.
Preterm infant
Avoidance of red blood cell transfusion in an extremely
preterm infant given recombinant human erythropoietin therapy.
J
Paediatr Child Health. 1994 Aug;30(4):360-2.
Erythropoietin in very preterm infants.
J
Paediatr Child Health. 1994 Aug;30(4):356-9.
Thermal injury
A conservative thermal injury treatment protocol for the
appropriate Jehovah's Witness candidate.
J
Burn Care Rehabil. 1997 Mar-Apr;18(2):133-8.
Anesthesia and intensive care management of severely
burned children of Jehovah's Witnesses.
Anaesthesist.
1996 Feb;45(2):171-5. German
Preventing blood transfusion in a severely burned Jehovah's
witness.
Chirurg.
1994 Nov;65(11):1066-8. German.
The use of recombinant human erythropoietin and cultured
epithelial autografts in a Jehovah's Witness with a major thermal injury.
Burns.
1994 Apr;20(2):176-7.
Successful use of recombinant human erythropoietin in
a Jehovah's Witness with a thermal injury.
J
Burn Care Rehabil. 1994 Jan-Feb;15(1):42-5.
Thoracic surgery
Lung transplantation in a Jehovah's Witness
J
Heart Lung Transplant 1999 Aug;18(8):796-800
Successful reoperation for ascending aorta and arch
aneurysm in a Jehovah's Witness.
Ann
Thorac Surg. 1994 Sep;58(3):871-3.
Thrombopoietin
Thrombopoietin induces rapid resolution of thrombocytopenia
after orthotopic liver transplantation
through increased platelet production
Blood
2000 95: 795-801
Risks, costs, and alternatives to platelet transfusions.
Leuk
Lymphoma. 1999 Jun;34(1-2):71-84.
Physiology and clinical applications of platelet growth
factors.
Curr
Opin Hematol. 1999 May;6(3):127-34.
Recombinant human thrombopoietin in combination with
granulocyte colony-stimulating factor enhances mobilization of peripheral
blood progenitor cells, increases peripheral blood platelet concentration,
and accelerates hematopoietic recovery following high-dose chemotherapy.
Blood.
1999 May 1;93(9):2798-806.
Thrombopoietic cytokines and reversal of thrombocytopenia
after liver transplantation.
Eur
J Gastroenterol Hepatol. 1999 Feb;11(2):151-6.
Thrombopoietin promotes hematopoietic recovery and survival
after high-dose whole body irradiation.
Int
J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):867-75.
Transfusion issues
Hepatitis-associated aplastic anemia and
transfusion-transmitted virus infection.
Intern
Med. 2000 Dec;39(12):1068-70.
Immunomodulatory Aspects of Transfusion: A Once and Future
Risk?
Anesthesiology.
1999 Sep;91(3):861-5. Review
Transfusion-Associated
Infections with Cytomegalovirus and Other Human Herpesviruses
Infusion Therapy and Transfusion Medicine 27:3:2000,
138-143.
Fulminant Non–A-G Viral Hepatitis Leading to
Liver Transplantation
Arch Intern Med. 2000;160:388-392
Prevalence of viral hepatitis C in patients with inflammatory
bowel disease in the region of nice and evaluation of risk factors
Gastroenterol
Clin Biol
2000 Jan;24(1):77-81
Patterns of and risk factors for recurrence after liver
resection for well-differentiated hepatocellular carcinoma: a special
reference to multicentric carcinogenesis after operation.
Hepatogastroenterology.
1999 Nov-Dec;46(30):3212-5.
Hepatitis C virus transmission
by a blood donation negative in nucleic acid amplification tests for viral
Lancet
2000 Jan 1;355(9197):41-2
Stored red blood cells selectively activate human
neutrophils to release IL-8 and secretory PLA2.
Shock.
2000 Jan;13(1):29-33.
Blood Transfusion First, Do No Harm!
Chest
1999 Nov; 116:1149-1150
Impact of Blood Transfusions on Inflammatory Mediator
Release in Patients Undergoing Cardiac Surgery
Chest,
1999 Nov; 116:1233-1239
Prevalence of TT virus in patients with fulminant
hepatic failure in Japan.
J
Gastroenterol 1999 Oct;34(5):589-93
The pathology of transfusion-related acute lung injury.
Am
J Clin Pathol. 1999 Aug;112(2):216-21.
Serious hazards of transfusion (SHOT) initiative:
analysis of the first two annual reports
BMJ
1999;319:16-19 ( 3 July )
Infections in Oncology: Infectious Causes of
Malignancy
Cancer
Control; JMCC 6(3):294-300, 1999
Viral etiology of human cancer: a historical perspective
Haematologica
1999 ; 385-389
Prognostic significance of perioperative blood transfusions
in resectable thoracic esophageal cancer.
Am
J Gastroenterol. 1999 Mar;94(3):757-65.
Hepatectomy for hepatocellular carcinoma: toward
zero hospital deaths.
Ann
Surg. 1999 Mar;229(3):322-30.
A multicenter, randomized, controlled clinical trial
of transfusion requirements in critical care. Transfusion Requirements
in Critical Care Investigators, Canadian Critical Care Trials Group.
N
Engl J Med. 1999 Feb 11;340(6):409-17.
Transfusions in Critically Ill Patients
N
Engl J Med 1999, Feb 11; 340 (6)
Prion diseases and blood transfusion
Transfus
Clin Biol. 1999 Feb;6(1):24-8. French.
New-variant Creutzfeldt-Jakob disease: the risk
of transmission by blood transfusion.
Blood
Rev. 1998 Dec;12(4):255-68. Review.
Emergence of new viral infections: implications
for the blood supply.
Biologicals.
1998 Jun;26(2):77-84. Review.
Adverse effect of perioperative blood transfusions on
survival after hepatic resection for hepatocellular carcinoma.
Hepatogastroenterology.
1997 Sep-Oct;44(17):1390-6.
Blood transfusion. An independent risk factor for postinjury
multiple organ failure.
Arch
Surg. 1997 Jun;132(6):620-4; discussion 624-5.
Transfusing red blood cells stored in citrate
phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation
in rats.
Crit
Care Med. 1997 May;25(5):726-32.
Transfusion of red cells is associated with increased
incidence of bacterial infection after colorectal surgery: a prospective
study.
Transfusion.
1997 Feb;37(2):126-34.
Effect of stored-blood transfusion on oxygen
delivery in patients with sepsis.
JAMA.
1993 Jun 16;269(23):3024-9.
Transfusion strategies
Critical oxygen delivery in conscious humans is less
than 7.3 ml O2 x kg(-1) x min(-1).
Anesthesiology.
2000 Feb;92(2):407-13.
Transfusion medicine. First of two parts--blood transfusion.
N
Engl J Med. 1999 Feb 11;340(6):438-47. Review. No abstract available.
Transfusion medicine. Second of two parts--blood conservation.
N
Engl J Med. 1999 Feb 18;340(7):525-33. Review. No abstract available.
Do we know when to transfuse red cells to treat
acute anemia?
Transfusion.
1998 Jun;38(6):517-21. Review. No abstract available.
Human cardiovascular and metabolic response to acute,
severe
isovolemic anemia.
JAMA.
1998 Jan 21;279(3):217-21.
New transfusion strategies.
Am
J Surg. 1997 Jan;173(1):49-52. Review.
Nursing strategies to minimize blood loss associated
with phlebotomy.
AACN
Clin Issues. 1996 May;7(2):277-87. Review.
Ten strategies to reduce blood loss in orthopedic
surgery.
Am
J Surg. 1995 Dec;170(6A Suppl):64S-68S.
Combined aprotinin and erythropoietin use for
blood conservation: results with Jehovah's Witnesses.
Ann
Thorac Surg. 1994 Nov;58(5):1397-403.
What can we learn about the need for transfusion from
patients
who refuse blood? The experience with Jehovah'sWitnesses.
Transfusion.
1994 May;34(5):396-401.
Are transfusions overrated? Surgical outcome of
Jehovah's Witnesses.
Am
J Med. 1993 Feb;94(2):117-9.
Management of the severely anemic patient who refuses
transfusion: lessons learned during the care of a Jehovah's Witness.
Ann
Intern Med. 1992 Dec 15;117(12):1042-8. Review.
Transplants
Trauma
Nonoperative management of a splenic tear in a
Jehovah's Witness with hemophilia.
J
Trauma. 1996 Feb;40(2):299-301. Review.
Traumatically injured Jehovah's Witnesses: a sixteen-year
experience of treatment and transfusion dilemmas at a level I trauma center.
J
Trauma. 1995 Oct;39(4):681-5.
Use of recombinant human erythropoietin (r-HuEPO) in
a Jehovah's Witness refusing transfusion of blood products: case
report.
J
Trauma. 1990 Nov;30(11):1406-8.
Urologic surgery
Acute normovolemic hemodilution can replace preoperative
autologous blood donation as a standard of care for autologous blood procurement
in radical prostatectomy.
Anesth
Analg. 1997 Nov;85(5):953-8.
Vascular surgery
Other
Treatment of chronic bleeding from gastric antral
vascular ectasia (GAVE) with estrogen-progesterone in
cirrhotic patients: an open pilot study.
Am
J Gastroenterol 1999 Oct;94(10):2909-11
|
